Telfast 180 mg filmom obložene tablete
| Name | Telfast 180 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-099579965 |
| Active Substance | feksofenadinklorid |
| Composition | jedna tableta sadrži 180 mg feksofenadinklorida, što odgovara količini od 168 mg feksofenadina |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Sanofi Winthrop Industrie, Tours, Francuska Opella Healthcare International SAS, Compiegne, Francuska |
| Marketing Authorisation Holder | Opella Healthcare France SAS, 157 avenue Charles de Gaulle, Neuilly-Sur-Seine, Francuska |
| Marketing Authorisation Date | 01.11.2021 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/14-02/363 |
| Registration Number | 381-12-01/154-21-29 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | R06AX26 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
